REFRACTORY HAIRY CELL LEUKEMIA

Clinical trials for REFRACTORY HAIRY CELL LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY HAIRY CELL LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New antibody tested for Tough-to-Treat blood cancers

Disease control Completed

This early-stage trial tested a new antibody drug called flotetuzumab in 13 patients with advanced blood cancers that had returned or stopped responding to standard treatments. The main goal was to find the safest dose and understand the drug's side effects. Researchers also look…

Matched conditions: REFRACTORY HAIRY CELL LEUKEMIA

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

REFRACTORY HAIRY CELL LEUKEMIA

Get alerted when new REFRACTORY HAIRY CELL LEUKEMIA trials appear

New antibody tested for Tough-to-Treat blood cancers